Home › Funds › Champlain Investment Partners, LLC › VCEL
Champlain Investment Partners, LLC position in VCEL
VERICEL CORP · Health Care
Champlain Investment Partners, LLC reported holding 755,828 shares of VCEL (VERICEL CORP) in its Q2 2026 13F filing — a position valued at US$33.6M, representing 0.86% of its reported portfolio and ranking #45 among its reported holdings. Champlain Investment Partners, LLC has disclosed VCEL holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Champlain Investment Partners, LLC's VCEL position evolved
Champlain Investment Partners, LLC first disclosed a stake in VCEL in Q4 2024 at 623,440 shares (US$34.2M). The position peaked in Q2 2025 at 997,291 shares, worth US$42.4M. Across 7 filings, Champlain Investment Partners, LLC increased the stake 2 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 755,828 shares valued at US$33.6M — a reduction of -59,345 shares quarter over quarter.. Notable position changes include a 62% increase in Q2 2025 (shares fell 26% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 623.44K | $34.23M | New |
| Q1 2025 | 613.79K | $27.39M | Reduce |
| Q2 2025 | 997.29K | $42.43M | Add |
| Q3 2025 | 987.60K | $31.08M | Reduce |
| Q4 2025 | 1.03M | $37.05M | Add |
| Q1 2026 | 815.17K | $26.22M | Reduce |
| Q2 2026 | 755.83K | $33.63M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About VCEL and 13F data
VCEL (VERICEL CORP) is a Health Care company. 32 other funds we track also report a position in VCEL — the largest reported positions include CONGRESS ASSET MANAGEMENT CO (US$102.4M), Conestoga Capital Advisors, LLC (US$92.7M), Soleus Capital Management, L.P. (US$64.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding VCEL
- CONGRESS ASSET MANAGEMENT CO 2.55M sh · $102.44M · Q3 2026
- Conestoga Capital Advisors, LLC 2.08M sh · $92.71M · Q2 2026
- Soleus Capital Management, L.P. 1.46M sh · $64.92M · Q2 2026
- GENEVA CAPITAL MANAGEMENT LLC 1.34M sh · $59.58M · Q2 2026
- NEXT CENTURY GROWTH INVESTORS LLC 612.58K sh · $27.25M · Q2 2026
- SG Capital Management LLC 571.25K sh · $25.42M · Q2 2026
- BROWN CAPITAL MANAGEMENT LLC 504.05K sh · $22.43M · Q2 2026
More on Champlain Investment Partners, LLC
FAQ
How long has Champlain Investment Partners, LLC held VCEL?
Champlain Investment Partners, LLC has disclosed VCEL holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
What is Champlain Investment Partners, LLC's current position in VCEL?
As of Q2 2026, Champlain Investment Partners, LLC holds 755.83K shares of VCEL (VERICEL CORP), valued at $33.63M, representing 0.86% of its reported portfolio and ranking #45.
Has Champlain Investment Partners, LLC been buying or selling VCEL?
In the latest 13F filing (Q2 2026), Champlain Investment Partners, LLC reduced its position in VCEL. The position peaked in Q2 2025 at 997.29K shares.
Which other funds hold VCEL?
Other major institutional holders of VCEL include CONGRESS ASSET MANAGEMENT CO, Conestoga Capital Advisors, LLC, Soleus Capital Management, L.P., among 32 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.